SB 1338 – Florida
Introduced: 2019 Status: Inactive / Dead
Prescription Drug Coverage; Authorizing the Office of Insurance Regulation to examine pharmacy benefit managers; requiring health insurers and health maintenance organizations, or pharmacy benefit managers on behalf of health insurers and health maintenance organizations, to …
SB 1393 – Arizona
Introduced: 2019 Status: Inactive / Dead
Coverage; formulary; changes prohibited; diabetes: An Act amending sections 20-841.05 and 20-1057.02, Arizona revised statutes; amending title 20, chapter 6, article 4, Arizona revised statutes, by adding section 20-1342.07; amending title 20, chapter 6, article …
SB 1412 – Illinois
Introduced: 2023 Status: In Process
Amends the Department of Healthcare and Family Services Law of the Civil Administrative Code of Illinois. Provides that the Department of Healthcare and Family Services shall implement and develop a program to establish a State …
SB 1604 – Illinois
Introduced: 2017 Status: Inactive / Dead
PHARMACY PRESCRIPTION DRUGS: Provides that if the substitute brand name drug product has a unit price greater than the unavailable generic drug product specified in the prescription, then the pharmacist shall dispense that substitute brand …
SB 1636 – Illinois
Introduced: 2023 Status: In Process
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely treatment of serious mental illnesses, prior authorization mandates and utilization management controls shall …
SB 164 – Louisiana
Introduced: 2019 Status: Inactive / Dead
Provides relative to the administration of prescription drug benefits. Present law requires insurers to provide certain override procedures for physicians when step therapy or fail first protocols are utilized. Proposed law retains present law and …
SB 1789 – Illinois
Introduced: 2021 Status: Inactive / Dead
Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for …
SB 188 – Connecticut
Introduced: 2022 Status: Inactive / Dead
AN ACT REQUIRING BRAND NAME PRESCRIPTION DRUG MANUFACTURERS TO PROVIDE SAMPLES OF BRAND NAME DRUGS TO GENERIC PRESCRIPTION DRUG MANUFACTURERS. To promote competition in the prescription drug market by allowing developers of generic drugs and …
SB 197 – Connecticut
Introduced: 2018 Status: Enacted
BIOLOGICAL PRODUCTS: Concerns biological products, adds biological products to existing law regarding substitution of generic drugs. Requires that within 48-hours of dispensing that the pharmacist shall inform the prescribing practitioner by facsimile, telephone or electronic …
SB 2008 (see companion bill HB 3630) – Illinois
Introduced: 2021 Status: Inactive / Dead
Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the federal Food and Drug Administration, plans that provide coverage for prescription drugs through the use …
SB 2047 – Illinois
Introduced: 2019 Status: Inactive / Dead
INS CD-AUTO INJECTORS. Amends the Illinois Insurance Code. Provides that a health insurer that provides prescription drug benefits shall offer generic alternatives to brand name epinephrine and insulin auto-injectors, where available.
SB 2365 (see companion bill HB 976) – Mississippi
Introduced: 2019 Status: Enacted
An Act To Amend Section 73-21-73, Mississippi Code Of 1972, To Define The Terms “biological Product” And “interchangeable Biological Product” And Revise The Definition Of The Term “product Selection” For The Purposes Of The Pharmacy …
SB 241 (see companion bill HB 2529) – Texas
Introduced: 2023 Status: Enacted
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
SB 245 – Alabama
Introduced: 2019 Status: Enacted
This bill would authorize a licensed pharmacist to dispense a substitute interchangeable biological product for certain biological products under certain conditions.
SB 262 – Connecticut
Introduced: 2021 Status: Inactive / Dead
AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS. To promote competition in the prescription drug market by allowing developers of generic drugs …
SB 350 – New Hampshire
Introduced: 2018 Status: Enacted
BIOLOGICAL PRODUCTS DISPENSED BY PHARMACISTS: A pharmacist shall substitute a biological product pursuant to this section only if it has been licensed by the federal Food and Drug Administration as an interchangeable biological product for …